Home › Funds › Bellevue Group AG › JNJ

Bellevue Group AG position in JNJ

JOHNSON & JOHNSON · Health Care

Bellevue Group AG reported holding 103,280 shares of JNJ (JOHNSON & JOHNSON) in its Q2 2026 13F filing — a position valued at US$26.2M, representing 0.55% of its reported portfolio and ranking #43 among its reported holdings. Bellevue Group AG has disclosed JNJ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)103.28K sh
Reported value held$26.23M
Portfolio Weight0.55%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Bellevue Group AG's JNJ position evolved

Bellevue Group AG first disclosed a stake in JNJ in Q3 2023 at 22,823 shares (US$3.6M). The position peaked in Q1 2026 at 119,102 shares, worth US$29.1M. Across 12 filings, Bellevue Group AG increased the stake 8 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 103,280 shares valued at US$26.2M — a reduction of -15,822 shares quarter over quarter.. Notable position changes include a 77% trim in Q1 2024 (shares fell 8% over the following quarter), a 557% increase in Q3 2024 (shares fell 11% over the following quarter), a 70% increase in Q4 2025 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 22.82K $3.55M New
Q4 2023 28.28K $4.43M Add
Q1 2024 6.42K $1.02M Reduce
Q2 2024 7.80K $1.14M Add
Q3 2024 51.24K $8.30M Add
Q4 2024 54.56K $7.89M Add
Q1 2025 67.01K $11.11M Add
Q2 2025 68.21K $10.42M Add
Q3 2025 74.81K $13.87M Add
Q4 2025 126.80K $26.24M Add
Q1 2026 119.10K $29.11M Reduce
Q2 2026 103.28K $26.23M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Bellevue Group AG held JNJ?

Bellevue Group AG has disclosed JNJ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Bellevue Group AG's current position in JNJ?

As of Q2 2026, Bellevue Group AG holds 103.28K shares of JNJ (JOHNSON & JOHNSON), valued at $26.23M, representing 0.55% of its reported portfolio and ranking #43.

Has Bellevue Group AG been buying or selling JNJ?

In the latest 13F filing (Q2 2026), Bellevue Group AG reduced its position in JNJ. The position peaked in Q1 2026 at 119.10K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.